Mascoma Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Mascoma Wealth Management's FBT Position: Q1 2026 in Review
Mascoma Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 98 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #262.
Mascoma Wealth Management first reported a position in FBT in Q1 2017 and has held it in 30 quarters since. The position peaked at $20.2K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Mascoma Wealth Management held 98 shares of First Trust NYSE Arca Biotechnology Index Fund worth $19.7K as of Q1 2026.
- Mascoma Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q1 2026, its #262 holding.
- Mascoma Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and has held it in 30 quarters since.
- Mascoma Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $20.2K in Q4 2025.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Mascoma Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.